113 related articles for article (PubMed ID: 33946014)
21. LncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma patients and regulates osteosarcoma cells proliferation and motility through modulating SOX2.
Wang Z; Tan M; Chen G; Li Z; Lu X
IUBMB Life; 2017 Nov; 69(11):867-876. PubMed ID: 28960757
[TBL] [Abstract][Full Text] [Related]
22. Expression of WNT-5a and ROR2 correlates with disease severity in osteosarcoma.
Lu BJ; Wang YQ; Wei XJ; Rong LQ; Wei D; Yan CM; Wang DJ; Sun JY
Mol Med Rep; 2012 Apr; 5(4):1033-6. PubMed ID: 22293903
[TBL] [Abstract][Full Text] [Related]
23. P63 expression as a biomarker discriminating giant cell tumor of bone from other giant cell-rich bone lesions.
Shooshtarizadeh T; Rahimi M; Movahedinia S
Pathol Res Pract; 2016 Oct; 212(10):876-879. PubMed ID: 27473669
[TBL] [Abstract][Full Text] [Related]
24. CCN3 Signaling Is Differently Regulated in Placental Diseases Preeclampsia and Abnormally Invasive Placenta.
Duan L; Schimmelmann M; Wu Y; Reisch B; Faas M; Kimmig R; Winterhager E; Köninger A; Gellhaus A
Front Endocrinol (Lausanne); 2020; 11():597549. PubMed ID: 33304321
[TBL] [Abstract][Full Text] [Related]
25. High-level expression of periostin is significantly correlated with tumour angiogenesis and poor prognosis in osteosarcoma.
Hu F; Shang XF; Wang W; Jiang W; Fang C; Tan D; Zhou HC
Int J Exp Pathol; 2016 Feb; 97(1):86-92. PubMed ID: 27028305
[TBL] [Abstract][Full Text] [Related]
26. CCN3 impairs osteoblast and stimulates osteoclast differentiation to favor breast cancer metastasis to bone.
Ouellet V; Tiedemann K; Mourskaia A; Fong JE; Tran-Thanh D; Amir E; Clemons M; Perbal B; Komarova SV; Siegel PM
Am J Pathol; 2011 May; 178(5):2377-88. PubMed ID: 21514448
[TBL] [Abstract][Full Text] [Related]
27. KAI-1 expression in pediatric high-grade osteosarcoma.
Leavey PJ; Timmons C; Frawley W; Lombardi D; Ashfaq R
Pediatr Dev Pathol; 2006; 9(3):219-24. PubMed ID: 16944980
[TBL] [Abstract][Full Text] [Related]
28. Report of four cases with high-grade surface osteosarcoma.
Hoshi M; Matsumoto S; Manabe J; Tanizawa T; Shigemitsu T; Takeuchi K; Kawaguchi N
Jpn J Clin Oncol; 2006 Mar; 36(3):180-4. PubMed ID: 16533804
[TBL] [Abstract][Full Text] [Related]
29. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis.
Zhu B; Cheng D; Li S; Zhou S; Yang Q
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455247
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA‑106a regulates the proliferation and invasion of human osteosarcoma cells by targeting VNN2.
Chen Y; Huang T; Yang X; Liu C; Li P; Wang Z; Zhi S
Oncol Rep; 2018 Oct; 40(4):2251-2259. PubMed ID: 30066949
[TBL] [Abstract][Full Text] [Related]
31. CCN3 is a therapeutic target relating enhanced stemness and coagulation in hepatocellular carcinoma.
Jia Q; Xue T; Zhang Q; Cheng W; Zhang C; Ma J; Bu Y; Yu S; Liu Q
Sci Rep; 2017 Oct; 7(1):13846. PubMed ID: 29061995
[TBL] [Abstract][Full Text] [Related]
32. [Expression and significance of N-cadherin and β-catenin protein in osteosarcoma].
Yang JZ; Zhang XH; Liu JR; Ding Y; Gao F; Wang Y
Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):586-9. PubMed ID: 21122409
[TBL] [Abstract][Full Text] [Related]
33. Dedifferentiated parosteal osteosarcoma with rhabdomyosarcomatous differentiation.
Reith JD; Donahue FI; Hornicek FJ
Skeletal Radiol; 1999 Sep; 28(9):527-31. PubMed ID: 10525797
[TBL] [Abstract][Full Text] [Related]
34. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.
Machado I; Navarro S; Picci P; Llombart-Bosch A
Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835
[TBL] [Abstract][Full Text] [Related]
35. Low grade central osteosarcoma--a diagnostic dilemma.
Kumar A; Varshney MK; Khan SA; Rastogi S; Safaya R
Joint Bone Spine; 2008 Oct; 75(5):613-5. PubMed ID: 18457982
[TBL] [Abstract][Full Text] [Related]
36. The many faces of osteosarcoma.
Murphey MD; Robbin MR; McRae GA; Flemming DJ; Temple HT; Kransdorf MJ
Radiographics; 1997; 17(5):1205-31. PubMed ID: 9308111
[TBL] [Abstract][Full Text] [Related]
37. [Histopathological diagnostic concordance in bone and soft tissue sarcomas between two comprehensive cancer centers from eastern and western Europe: a collaborative experience].
Somcutian O; Buiga R; Galatir M; Tudor Eniu D; Rachieru C; Coza D; Terrier P
Ann Pathol; 2015 Jan; 35(1):32-40. PubMed ID: 25541117
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary Relapse of Osteosarcoma Following Presentation With a Pneumomediastinum and Localized Disease at Diagnosis.
Kumar S; Alazraki A; George B; Martin M; Katzenstein HM; Cash T
J Pediatr Hematol Oncol; 2017 Nov; 39(8):e446-e449. PubMed ID: 28306689
[TBL] [Abstract][Full Text] [Related]
39. Pediatric bone tumors.
Yaw KM
Semin Surg Oncol; 1999 Mar; 16(2):173-83. PubMed ID: 9988871
[TBL] [Abstract][Full Text] [Related]
40. Parosteal osteosarcoma.
Hang JF; Chen PC
Arch Pathol Lab Med; 2014 May; 138(5):694-9. PubMed ID: 24786129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
